Cargando…
Protein Modifications as Potential Biomarkers in Breast Cancer
A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805424/ https://www.ncbi.nlm.nih.gov/pubmed/20072669 |
_version_ | 1782176193056866304 |
---|---|
author | Jin, Hongjun Zangar, Richard C. |
author_facet | Jin, Hongjun Zangar, Richard C. |
author_sort | Jin, Hongjun |
collection | PubMed |
description | A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying changes in PTMs. In this review, we summarize the current literature on PTMs identified in the plasma and tumor tissue of breast-cancer patients or in breast cell lines. We also discuss some of the analytical techniques currently being used to evaluate PTMs. |
format | Text |
id | pubmed-2805424 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-28054242010-01-13 Protein Modifications as Potential Biomarkers in Breast Cancer Jin, Hongjun Zangar, Richard C. Biomark Insights Review A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying changes in PTMs. In this review, we summarize the current literature on PTMs identified in the plasma and tumor tissue of breast-cancer patients or in breast cell lines. We also discuss some of the analytical techniques currently being used to evaluate PTMs. Libertas Academica 2009-11-30 /pmc/articles/PMC2805424/ /pubmed/20072669 Text en © 2009 The authors. http://creativecommons.org/licenses/by/2.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/2.0/). |
spellingShingle | Review Jin, Hongjun Zangar, Richard C. Protein Modifications as Potential Biomarkers in Breast Cancer |
title | Protein Modifications as Potential Biomarkers in Breast Cancer |
title_full | Protein Modifications as Potential Biomarkers in Breast Cancer |
title_fullStr | Protein Modifications as Potential Biomarkers in Breast Cancer |
title_full_unstemmed | Protein Modifications as Potential Biomarkers in Breast Cancer |
title_short | Protein Modifications as Potential Biomarkers in Breast Cancer |
title_sort | protein modifications as potential biomarkers in breast cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805424/ https://www.ncbi.nlm.nih.gov/pubmed/20072669 |
work_keys_str_mv | AT jinhongjun proteinmodificationsaspotentialbiomarkersinbreastcancer AT zangarrichardc proteinmodificationsaspotentialbiomarkersinbreastcancer |